Login or Register for additional
programming information
Program Description
While vaccines have emerged to treat a cancer caused by human papilloma virus, there is still a need for therapies to treat cancerous tissue caused by HPV. John Docherty, president of Toronto-based Helix BioPharma, tells host Bruce Japsen about his company's research and that of the biotech industry in the study and treatment of HPV, a key virus in the development of cervical cancer.
Series
Focus on Cancer
Guest
John Docherty
John Docherty is president of Helix BioPharma in Toronto, Canada. Mr. Docherty joined the company in 1999. He has degrees in toxicology and pharmacol...more
Hosted by
Back To Program List